Company Directory / biotech/health
PrivateFor profitbiotech/healthHamburg, Germany
Cara Care
Cara Care is a digital health platform that offers an app-based treatment to help patients with chronic gastrointestinal problems.
- Founded
- 2016 10 years ago
- Staff
- 51-100 band, as listed
- Followers
- - on LinkedIn
- Funding
- $16M as listed, currency not stated
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed
Age
10 years old.
Reach
Website ranked #170,096 in the world for traffic, about 270k visits a month.
What it does
AppsHealth CareHealth DiagnosticsMedicalMedical DeviceTherapeutics
Funding, as listed
$16M currency not stated
- Rounds6
- LatestSeries a, Jun 2022
- Investors9, 4 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Cara Care, field by field. Contact details are held but never shown.
The company
- Name
- Cara Care
- Type
- For profit
- Status
- Private
- Founded
- 2016
- Founders
- Andre Sommer, Dankrad Feist, Jesaja Brinkmann, Orest Tarasiuk
- Industry
- biotech/health
- Categories
- Apps, Health Care, Health Diagnostics, Medical, Medical Device, Therapeutics
Where
- City
- Hamburg
- Country
- Germany
- Markets
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 51-100
- Web traffic rank
- #170,096
- Monthly web visits
- 270,380
- Apps
- 2
- App downloads
- 2,050
Funding, as listed
- Total
- 16,000,000 (currency not stated)
- Rounds
- 6
- Latest round
- Series a
- Latest round date
- Jun 2022
- Investors
- 9
- Lead investors
- 4
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Cara Care may be growing as evidenced by its acquisition by Mahana Therapeutics, which is a significant move that typically indicates a positive valuation and a strategic fit for the acquiring company. The acquisition aims to position Mahana Therapeutics as a global leader in the digital treatment of chronic conditions, suggesting that Cara Care's offerings are valuable in the digital health market. This move could also imply an expansion of Cara Care's reach and capabilities under the umbrella of Mahana Therapeutics, potentially leading to increased market presence and operational scale.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
biotech/health in Germany.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 106,645 companies in Germany and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.